Ascendis Pharma A (ASND) Cash from Investing Activities (2014 - 2018)

Ascendis Pharma A has disclosed Cash from Investing Activities across 5 years of filings, most recently posting -$125310.3 for Q1 2018.

• Cash from Investing Activities for Q1 2018 came in at -$125310.3, up 68.8% year-over-year; the trailing twelve-month figure through Mar 2018 was -$1.1 million (down 3.05% YoY), and the FY2025 annual result was -$9.9 million, down 234.42% from the prior year.
• Cash from Investing Activities came in at -$125310.3 for Q1 2018 at Ascendis Pharma A, up from -$401658.4 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$48743.5 in Q4 2014 to a low of -$559201.5 in Q2 2015.
• The 5-year median for Cash from Investing Activities is -$152215.7 (2016), against an average of -$215888.2.
• Across the five-year window, Cash from Investing Activities sank 716.29% in 2015 and soared 68.8% in 2018, its largest moves.
• Ascendis Pharma A's Cash from Investing Activities stood at -$48743.5 in 2014, then sank by 716.29% to -$397890.6 in 2015, then soared by 61.74% to -$152215.7 in 2016, then sank by 163.87% to -$401658.4 in 2017, then jumped by 68.8% to -$125310.3 in 2018.
• The last three Cash from Investing Activities figures came in at -$125310.3 (Q1 2018), -$401658.4 (Q1 2017), and -$152215.7 (Q1 2016), per Business Quant data.